Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch...
Researchers at the University of Edinburgh say CBD is a “promising therapeutic agent” due to its varying effects on the body.
MRX1 demonstrated “cardioprotective effects” in a pre-clinical study.